Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing.

Area of Science:

• Biotechnology
• Genetics
• Molecular Biology

Background:

• The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system is a key technology for genetic engineering.
• CRISPR/Cas9 enables precise gene editing with significant potential in biotechnology.
• Generating transgenic animals efficiently is crucial for research and development.

Purpose of the Study:

• To investigate the effect of valproic acid (VPA) on CRISPR/Cas9-mediated gene editing efficiency.
• To determine if VPA can improve the generation of transgenic systems.
• To explore the mechanism behind VPA's potential enhancement of gene editing.

Main Methods:

• Utilizing CRISPR/Cas9 technology for gene editing in mouse embryonic stem cells and embryos.
• Administering valproic acid (VPA), a histone deacetylase inhibitor.
• Assessing gene editing efficiency post-VPA treatment.
• Analyzing chromatin accessibility through histone acetylation levels.

Main Results:

• Valproic acid (VPA) significantly increased the efficiency of CRISPR/Cas9-mediated gene editing.
• VPA treatment led to globally enhanced chromatin accessibility.
• Histone hyperacetylation was observed, correlating with increased accessibility.
• The efficacy of generating transgenic systems was improved by VPA.

Conclusions:

• Valproic acid (VPA) is an effective enhancer for CRISPR/Cas9 gene editing.
• VPA's mechanism involves increasing chromatin accessibility and histone acetylation.
• VPA shows promise for improving the generation of transgenic animals and other biotechnological applications.